-
公开(公告)号:US20120238852A1
公开(公告)日:2012-09-20
申请号:US13460365
申请日:2012-04-30
申请人: James H. Brauker , Mark A. Tapsak , Sean T. Saint , Apurv U. Kamath , Paul V. Neale , Peter C. Simpson , Michael Robert Mensinger , Dubravka Markovic
发明人: James H. Brauker , Mark A. Tapsak , Sean T. Saint , Apurv U. Kamath , Paul V. Neale , Peter C. Simpson , Michael Robert Mensinger , Dubravka Markovic
CPC分类号: A61M5/31525 , A61B5/0002 , A61B5/14532 , A61B5/1486 , A61B5/14865 , A61B5/4839 , A61B2560/0443 , A61M5/1723 , A61M11/00 , A61M15/0001 , A61M2005/1726 , A61M2205/18 , A61M2205/3303 , A61M2205/502 , A61M2205/52 , A61M2230/201 , G06F19/00 , G06F19/3468 , G16H20/17 , G16H40/63
摘要: Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.
-
公开(公告)号:US08255033B2
公开(公告)日:2012-08-28
申请号:US11410392
申请日:2006-04-25
CPC分类号: A61B5/1473 , A61B5/145 , A61B5/14503 , A61B5/14532 , A61B5/14546 , A61B5/1468 , A61B5/14735 , A61B5/14865
摘要: The present invention relates generally to systems and methods for increasing oxygen availability to implantable devices. The preferred embodiments provide a membrane system configured to provide protection of the device from the biological environment and/or a catalyst for enabling an enzymatic reaction, wherein the membrane system includes a polymer formed from a high oxygen soluble material. The high oxygen soluble polymer material is disposed adjacent to an oxygen-utilizing source on the implantable device so as to dynamically retain high oxygen availability to the oxygen-utilizing source during oxygen deficits. Membrane systems of the preferred embodiments are useful for implantable devices with oxygen-utilizing sources and/or that function in low oxygen environments, such as enzyme-based electrochemical sensors and cell transplantation devices.
-
公开(公告)号:US08255030B2
公开(公告)日:2012-08-28
申请号:US11410555
申请日:2006-04-25
CPC分类号: A61B5/1473 , A61B5/145 , A61B5/14503 , A61B5/14532 , A61B5/14546 , A61B5/1468 , A61B5/14735 , A61B5/14865
摘要: The present invention relates generally to systems and methods for increasing oxygen availability to implantable devices. The preferred embodiments provide a membrane system configured to provide protection of the device from the biological environment and/or a catalyst for enabling an enzymatic reaction, wherein the membrane system includes a polymer formed from a high oxygen soluble material. The high oxygen soluble polymer material is disposed adjacent to an oxygen-utilizing source on the implantable device so as to dynamically retain high oxygen availability to the oxygen-utilizing source during oxygen deficits. Membrane systems of the preferred embodiments are useful for implantable devices with oxygen-utilizing sources and/or that function in low oxygen environments, such as enzyme-based electrochemical sensors and cell transplantation devices.
-
公开(公告)号:US20120190953A1
公开(公告)日:2012-07-26
申请号:US13436534
申请日:2012-03-30
申请人: James H. Brauker , Mark A. Tapsak , Sean T. Saint , Apurv U. Kamath , Paul V. Neale , Peter C. Simpson , Michael Robert Mensinger , Dubravka Markovic
发明人: James H. Brauker , Mark A. Tapsak , Sean T. Saint , Apurv U. Kamath , Paul V. Neale , Peter C. Simpson , Michael Robert Mensinger , Dubravka Markovic
IPC分类号: A61B5/145
CPC分类号: A61M5/31525 , A61B5/0002 , A61B5/14532 , A61B5/1486 , A61B5/14865 , A61B5/4839 , A61B2560/0443 , A61M5/1723 , A61M11/00 , A61M15/0001 , A61M2005/1726 , A61M2205/18 , A61M2205/3303 , A61M2205/502 , A61M2205/52 , A61M2230/201 , G06F19/3468 , G16H20/17 , G16H40/63
摘要: Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.
-
公开(公告)号:US07881763B2
公开(公告)日:2011-02-01
申请号:US11415631
申请日:2006-05-02
IPC分类号: A61B5/1473
CPC分类号: A61B5/6882 , A61B5/0031 , A61B5/14532 , A61B5/14546 , A61B5/1486 , A61B5/415 , A61B5/418 , A61B2562/187
摘要: An implantable sensor for use in measuring a concentration of an analyte such as glucose in a bodily fluid, including a body with a sensing region adapted for transport of analytes between the sensor and the bodily fluid, wherein the sensing region is located on a curved portion of the body such that when a foreign body capsule forms around the sensor, a contractile force is exerted by the foreign body capsule toward the sensing region. The body is partially or entirely curved, partially or entirely covered with an anchoring material for supporting tissue ingrowth, and designed for subcutaneous tissue implantation. The geometric design, including curvature, shape, and other factors minimize chronic inflammatory response at the sensing region and contribute to improved performance of the sensor in vivo.
摘要翻译: 一种用于测量体液中诸如葡萄糖的分析物的浓度的植入式传感器,其包括具有适于在所述传感器和所述体液之间输送分析物的感测区域的身体,其中所述感测区域位于弯曲部分上 使得当异物体胶囊围绕传感器形成时,异物胶囊朝向感测区域施加收缩力。 身体部分或完全弯曲,部分或完全覆盖有用于支撑组织向内生长的锚固材料,并被设计用于皮下组织植入。 几何设计,包括曲率,形状和其他因素最大限度地减少传感区域的慢性炎症反应,并有助于改善体内传感器的性能。
-
公开(公告)号:US20100256779A1
公开(公告)日:2010-10-07
申请号:US11654135
申请日:2007-01-17
CPC分类号: A61L31/146 , A61L31/10 , A61L31/14
摘要: A membrane for implantation in soft tissue comprising a first domain that supports tissue ingrowth, disrupts contractile forces typically found in a foreign body response, encourages vascularity, and interferes with barrier cell layer formation, and a second domain that is resistant to cellular attachment, is impermeable to cells and cell processes, and allows the passage of analytes. The membrane allows for long-term analyte transport in vivo and is suitable for use as a biointerface for implantable analyte sensors, cell transplantation devices, drug delivery devices, and/or electrical signal delivering or measuring devices. The membrane architecture, including cavity size, depth, and interconnectivity, provide long-term robust functionality of the membrane in vivo.
摘要翻译: 用于植入软组织中的膜包括支撑组织向内生长的第一结构域,破坏通常在异物反应中发现的收缩力,促进血管分布,并妨碍阻隔细胞层的形成,以及抵抗细胞附着的第二结构域是 对细胞和细胞过程不可渗透,并允许分析物通过。 该膜允许体内长期的分析物输送,并且适用于可植入分析物传感器,细胞移植装置,药物递送装置和/或电信号传递或测量装置的生物界面。 膜结构,包括腔体尺寸,深度和互连性,在体内提供膜的长期稳定的功能。
-
公开(公告)号:US07761130B2
公开(公告)日:2010-07-20
申请号:US11692154
申请日:2007-03-27
申请人: Peter C. Simpson , James H. Brauker , Paul V. Goode , Apurv U. Kamath , James R. Petisce , Kum Ming Woo , Melissa A. Nicholas , Robert J. Boock , Monica A. Rixman , John Burd , Rathbun K. Rhodes , Mark A. Tapsak
发明人: Peter C. Simpson , James H. Brauker , Paul V. Goode , Apurv U. Kamath , James R. Petisce , Kum Ming Woo , Melissa A. Nicholas , Robert J. Boock , Monica A. Rixman , John Burd , Rathbun K. Rhodes , Mark A. Tapsak
IPC分类号: A61B5/00
CPC分类号: A61B5/1495 , A61B5/14532 , A61B5/14865 , B33Y70/00
摘要: Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure analyte or non-analyte related signal, both of which electrode include an interference domain.
摘要翻译: 本文公开了用于连续分析物传感器(例如连续葡萄糖传感器)的系统和方法。 一个这样的系统利用第一和第二工作电极来测量分析物或非分析物相关的信号,这两个电极都包括干涉域。
-
公开(公告)号:US20090299276A1
公开(公告)日:2009-12-03
申请号:US12536852
申请日:2009-08-06
申请人: James H. Brauker , Mark A. Tapsak , Sean T. Saint , Apurv U. Kamath , Paul V. Neale , Peter C. Simpson , Michael Robert Mensinger , Dubravka Markovic
发明人: James H. Brauker , Mark A. Tapsak , Sean T. Saint , Apurv U. Kamath , Paul V. Neale , Peter C. Simpson , Michael Robert Mensinger , Dubravka Markovic
CPC分类号: A61M5/31525 , A61B5/0002 , A61B5/14532 , A61B5/1486 , A61B5/14865 , A61B5/4839 , A61B2560/0443 , A61M5/1723 , A61M11/00 , A61M15/0001 , A61M2005/1726 , A61M2205/18 , A61M2205/3303 , A61M2205/502 , A61M2205/52 , A61M2230/201 , G06F19/00 , G06F19/3468 , G16H20/17 , G16H40/63
摘要: Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.
摘要翻译: 提供了用于集成包括接收器,药物输送装置和任选的单点葡萄糖监测器的连续葡萄糖传感器的系统和方法。 手动集成提供了用户(例如,患者或医生)手动选择数量,类型和/或递送时间的设备之间的物理关联。 设备的半自动化集成包括集成,其中集成组件之间的可操作连接有助于用户(例如患者或医生)在选择,输入,计算或验证葡萄糖值的药物递送量,类型或时间 例如,通过将数据发送到另一个组件,从而减少所需的用户输入量。 设备之间的自动集成包括集成,其中集成组件之间的可操作连接提供对系统的完全控制,而不需要用户交互。
-
公开(公告)号:US20090076356A1
公开(公告)日:2009-03-19
申请号:US12264160
申请日:2008-11-03
申请人: Peter C. Simpson , James H. Brauker , Paul V. Goode , Apurv U. Kamath , James R. Petisce , Kum Ming Woo , Melissa A. Nicholas , Robert J. Boock , Monica A. Rixman , John Burd , Rathburn K. Rhodes , Mark A. Tapsak
发明人: Peter C. Simpson , James H. Brauker , Paul V. Goode , Apurv U. Kamath , James R. Petisce , Kum Ming Woo , Melissa A. Nicholas , Robert J. Boock , Monica A. Rixman , John Burd , Rathburn K. Rhodes , Mark A. Tapsak
IPC分类号: A61B5/145
CPC分类号: A61B5/1495 , A61B5/14532 , A61B5/14865 , B33Y70/00
摘要: Disclosed herein are systems and methods for a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes first and second working electrodes to measure analyte or non-analyte related signal, both of which electrode include an interference domain.
摘要翻译: 本文公开了用于连续分析物传感器(例如连续葡萄糖传感器)的系统和方法。 一个这样的系统利用第一和第二工作电极来测量分析物或非分析物相关的信号,这两个电极都包括干涉域。
-
公开(公告)号:US08909314B2
公开(公告)日:2014-12-09
申请号:US13187277
申请日:2011-07-20
申请人: James R. Petisce , Mark A. Tapsak , Peter C. Simpson , Victoria E. Carr-Brendel , James H. Brauker
发明人: James R. Petisce , Mark A. Tapsak , Peter C. Simpson , Victoria E. Carr-Brendel , James H. Brauker
IPC分类号: A61B5/145 , A61B5/1468 , A61B5/1473 , A61B5/1486
CPC分类号: A61B5/1473 , A61B5/145 , A61B5/14503 , A61B5/14532 , A61B5/14546 , A61B5/1468 , A61B5/14735 , A61B5/14865
摘要: The present invention relates generally to systems and methods for increasing oxygen availability to implantable devices. The preferred embodiments provide a membrane system configured to provide protection of the device from the biological environment and/or a catalyst for enabling an enzymatic reaction, wherein the membrane system includes a polymer formed from a high oxygen soluble material. The high oxygen soluble polymer material is disposed adjacent to an oxygen-utilizing source on the implantable device so as to dynamically retain high oxygen availability to the oxygen-utilizing source during oxygen deficits. Membrane systems of the preferred embodiments are useful for implantable devices with oxygen-utilizing sources and/or that function in low oxygen environments, such as enzyme-based electrochemical sensors and cell transplantation devices.
摘要翻译: 本发明一般涉及用于增加可植入装置的氧气可用性的系统和方法。 优选的实施方案提供了一种膜系统,其被配置为提供该装置与生物环境的保护和/或用于实现酶反应的催化剂,其中所述膜系统包括由高氧可溶性材料形成的聚合物。 高氧可溶性聚合物材料与可植入装置上的氧气源相邻设置,以便在缺氧期间动态地保持氧利用源的高氧可利用性。 优选实施方案的膜系统对于具有氧利用源的可植入装置和/或在低氧环境中起作用,例如基于酶的电化学传感器和细胞移植装置是有用的。
-
-
-
-
-
-
-
-
-